News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,515 Results
Type
Article (17366)
Company Profile (128)
Press Release (163021)
Section
Business (58122)
Career Advice (933)
Deals (9336)
Drug Delivery (34)
Drug Development (23362)
Employer Resources (70)
FDA (2316)
Job Trends (4213)
News (92052)
Policy (5772)
Tag
Academia (480)
Alliances (16163)
Alzheimer's disease (394)
Antibody-drug conjugate (ADC) (56)
Approvals (2284)
Artificial intelligence (65)
Bankruptcy (76)
Best Places to Work (2873)
Biotechnology (118)
Breast cancer (66)
Cancer (555)
Career advice (752)
CAR-T (63)
Cell therapy (183)
Clinical research (18243)
Collaboration (263)
Compensation (52)
COVID-19 (733)
C-suite (77)
Data (499)
Diabetes (46)
Diagnostics (1044)
Drug discovery (45)
Earnings (15610)
Employer resources (68)
Events (30743)
Executive appointments (226)
FDA (2489)
Funding (223)
Gene therapy (118)
GLP-1 (235)
Government (608)
Healthcare (2361)
Infectious disease (775)
Inflammatory bowel disease (58)
Interviews (136)
IPO (4068)
Job creations (1470)
Job search strategy (699)
Layoffs (137)
Legal (1174)
Lung cancer (62)
Lymphoma (44)
Manufacturing (107)
Medical device (674)
Medtech (675)
Mergers & acquisitions (5372)
Metabolic disorders (166)
Neuroscience (536)
NextGen Class of 2024 (1435)
Non-profit (449)
Northern California (623)
Obesity (91)
Opinion (166)
Patents (45)
People (21828)
Phase I (7094)
Phase II (8701)
Phase III (4908)
Pipeline (228)
Postmarket research (306)
Preclinical (2894)
Press Release (61)
Radiopharmaceuticals (79)
Rare diseases (119)
Real estate (2431)
Regulatory (4367)
Research institute (515)
Resumes & cover letters (152)
Series A (49)
Southern California (591)
Startups (1774)
United States (5258)
Vaccines (185)
Weight loss (70)
Date
Last 7 days (123)
Last 30 days (859)
Last 365 days (12670)
2024 (12641)
2023 (13209)
2022 (16051)
2021 (16966)
2020 (13193)
2019 (9509)
2018 (7541)
2017 (8984)
2016 (8118)
2015 (9419)
2014 (9737)
2013 (9459)
2012 (6090)
2011 (6455)
2010 (5841)
Location
Africa (323)
Asia (13318)
Australia (2651)
California (1447)
Canada (531)
China (127)
Connecticut (59)
Europe (29825)
Florida (148)
Illinois (105)
Indiana (77)
Maryland (224)
Massachusetts (1150)
Michigan (64)
Minnesota (97)
New Jersey (411)
New York (361)
North Carolina (273)
Northern California (623)
Ohio (41)
Pennsylvania (313)
South America (401)
Southern California (591)
Texas (157)
Washington State (260)
180,515 Results for "sartorius stedim biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA
November 22, 2024
·
3 min read
Business
Preliminary results 2022 of Sartorius Stedim Biotech
Following extraordinary growth in 2020 and 2021, Sartorius Stedim Biotech, a leading partner of the biopharma industry, again outperformed the market in fiscal 2022.
January 26, 2023
·
11 min read
Nine-month results 2022 of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, closed the first nine months of 2022 with double-digit sales revenue and earnings growth and specified its outlook for the current fiscal year.
October 19, 2022
·
10 min read
Business
Half-year results 2022 of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, increased sales revenue and earnings with double-digit growth rates in the first half of 2022 and confirmed its full-year outlook.
July 21, 2022
·
9 min read
Business
First-quarter results 2022 of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, recorded a dynamic start to fiscal 2022, with sales revenue and earnings posting strong double-digit growth rates in the first quarter compared with the prior-year period.
April 21, 2022
·
9 min read
Business
Nine-month results of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, has continued to grow dynamically and profitably.
October 20, 2021
·
11 min read
Preliminary results 2021 of Sartorius Stedim Biotech
Sartorius Stedim Biotech, a leading partner of the biopharma industry, closed fiscal 2021 with exceptionally strong growth and a jump in profitability due to the excellent development of its core business, additional demand generated by the coronavirus pandemic, and several acquisitions.
January 27, 2022
·
14 min read
Deals
Sartorius Stedim Biotech completes acquisition of Novasep’s chromatography division
Sartorius Stedim Biotech, a leading partner of the biopharma industry, announced that it closed the acquisition of the Novasep chromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission.
February 8, 2022
·
3 min read
Business
Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor
The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park.
June 6, 2024
·
3 min read
Funding
Navigating a Biotech Exit in a Rebounding Market
With climbing biotech M&A and IPO activity following the post-pandemic slump, experts offer insights on maximizing value and otherwise capitalizing on exit opportunities.
November 6, 2024
·
8 min read
·
Ana Mulero
1 of 18,052
Next
